✦ LIBER ✦

Risk factors and antiplatelet therapy in TIA and stroke patients

✍ Scribed by Juha Puranen; Markku Laakso; Paavo Riekkinen Sr.; Juhani Sivenius

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiplatelet therapy and risk of stroke

✍ Hennekens, Charles H.; Jonas, Michael A.; Buring, Julie E. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 401 KB

Knowledge of stroke warning signs and ri

✍ Ying Zeng; Guo-Ping He; Guang-Hui Yi; Yan-Jin Huang; Qing-Hai Zhang; Ling-Ling H 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

Is clopidogrel the antiplatelet drug of

✍ G. J. HANKEY 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Is clopidogrel the antiplatelet drug of

✍ H.-C. DIENER 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Prior therapy with antiplatelet agents i

✍ S. Greisenegger; S. Tentschert; M. Weber; J. Ferrari; W. Lang; W. Lalouschek 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 206 KB

Platelet activation and antiplatelet the

✍ Shinichiro Uchiyama; Tomomi Nakamura; Masako Yamazaki; Yukiko Tsutsumi; Makoto I 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 424 KB